In the first quarter, BioCryst swung to a profit of $32,000, or less than a penny a share from a loss of $35.4 million, or 17 cents a share, a year earlier. Revenue surged 57% to $145.5 million, ...

Dundee Precious Metals said Monday it has appointed Juanita Montalvo as board chair following the passing of Peter Gillin, who previously served in the role. Gillin first joined the Toronto-based gold ...

Have an issue with your financial planner or looking for a new one? Email questions or concerns to [email protected].

ImmunityBio is seeking an urgent meeting with U.S. health regulators after its bladder-cancer treatment application was rejected. The immunotherapy company said Monday that it received a ...

Dr. Peter Marks, a Food and Drug Administration official who had a leading role in vaccine regulation, was ousted by Health and Human Services Secretary Robert F. Kennedy Jr., and alleged Kennedy was ...

Elanco Animal Health has sold royalty and milestone rights for Xdemvy's human health applications to Blackstone-affiliated funds for $295 million. The animal-medicine company said Monday that the ...

Freshpet trimmed its outlook for the year to plan as if first-quarter conditions were to continue for the balance of the year, said Chief Executive Billy Cyr. "Our growth year-to-date has not been as ...

These were some of the most active shares ahead of Monday's market open: Netflix shares fell over 4%. President Donald Trump said over the weekend that [U.S. movies made overseas would be subject to 1 ...

Federal Reserve Chair Jerome Powell will push back at his press conference on Wednesday on calls from the White House and ...

Shares of Warner Bros Discovery, which operates the Max streaming service and HBO cable channel in addition to a major Hollywood studio, fell 2.7% to $8.31 premarket. Many major Warner Brothers ...

The revised outlook also incorporates the impact of Zimmer Biomet's acquisition of orthopedic foot and ankle company Paragon 28 and current tariff proposals, the company said.

Enghouse Systems on Monday said that it plans to renew its share repurchase program to buy about 7% of its share over the course of a one-year period. The Canadian enterprise software solutions ...